clofibric acid and gw9662

clofibric acid has been researched along with gw9662 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kim, HT; Kim, SH; Kim, YK; Kwon, CH; Park, JY; Yoo, CI	1

Other Studies

1 other study(ies) available for clofibric acid and gw9662

Article	Year
Activation of peroxisome proliferator-activated receptor-gamma (PPARgamma) induces cell death through MAPK-dependent mechanism in osteoblastic cells. Toxicology and applied pharmacology, 2006, Sep-01, Volume: 215, Issue:2 Topics: 3T3 Cells; Anilides; Animals; Antioxidants; Apoptosis; Cell Survival; Chromans; Clofibric Acid; Dose-Response Relationship, Drug; Drug Antagonism; Enzyme Activation; Enzyme Inhibitors; Fibric Acids; Hypoglycemic Agents; Mice; Mitogen-Activated Protein Kinases; Osteoblasts; p38 Mitogen-Activated Protein Kinases; PPAR gamma; Reactive Oxygen Species; Thiazolidinediones; Troglitazone	2006

Article

Year

Activation of peroxisome proliferator-activated receptor-gamma (PPARgamma) induces cell death through MAPK-dependent mechanism in osteoblastic cells.

Toxicology and applied pharmacology, 2006, Sep-01, Volume: 215, Issue:2

Topics: 3T3 Cells; Anilides; Animals; Antioxidants; Apoptosis; Cell Survival; Chromans; Clofibric Acid; Dose-Response Relationship, Drug; Drug Antagonism; Enzyme Activation; Enzyme Inhibitors; Fibric Acids; Hypoglycemic Agents; Mice; Mitogen-Activated Protein Kinases; Osteoblasts; p38 Mitogen-Activated Protein Kinases; PPAR gamma; Reactive Oxygen Species; Thiazolidinediones; Troglitazone

2006